Successful treatment of imatinib-resistant hypereosinophilic syndrome with nilotinib. (Record no. 19666788)

MARC details
000 -LEADER
fixed length control field 01398 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515214233.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201006s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1873-5835
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.leukres.2010.02.024
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Ikezoe, Takayuki
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20100624
245 00 - TITLE STATEMENT
Title Successful treatment of imatinib-resistant hypereosinophilic syndrome with nilotinib.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Leukemia research
Date of publication, distribution, etc. Aug 2010
300 ## - PHYSICAL DESCRIPTION
Extent e200-1 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Benzamides
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Resistance, Neoplasm
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hypereosinophilic Syndrome
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Imatinib Mesylate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Piperazines
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein-Tyrosine Kinases
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrimidines
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Salvage Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Togitani, Kazuto
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tasaka, Taizo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nishioka, Chie
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Yokoyama, Akihito
773 0# - HOST ITEM ENTRY
Title Leukemia research
Related parts vol. 34
-- no. 8
-- p. e200-1
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.leukres.2010.02.024">https://doi.org/10.1016/j.leukres.2010.02.024</a>
Public note Available from publisher's website

No items available.